Get started
Author

Kimimori Kamijo

Observed names: Kamijo, Kimimori, Kimimori Kamijyo
ORCID: 0000-0002-3267-2018
Observed ORCID: 0000-0002-3267-2018
OpenAlex ID: A5063937976
Clinical features and outcomes of duodenal‐type follicular lymphoma: A single‐center retrospective study
2022 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · eJHaem · 17
PDF
Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
2023 · Masashi Nishikubo, Yoshimitsu Shimomura, et al. · Blood Cancer Journal · 7
PDF
Humoral response and safety of the BNT162b2 and mRNA ‐1273 COVID ‐19 vaccines in patients with haematological diseases treated with anti‐CD20 antibodies: An observational study
2022 · Masashi Nishikubo, Yoshimitsu Shimomura, et al. · British Journal of Haematology · 7
PDF
BCR/ABL1-positive B-lymphoblastic Lymphoma Successfully Treated with Dasatinib-combined Chemotherapy
2021 · Chika Yamada, Yoshimitsu Shimomura, et al. · Internal Medicine · 6
PDF
Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation
2021 · Masatoshi Sakurai, Takehiko Mori, et al. · Bone Marrow Transplantation · 6
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study
2022 · Masashi Nishikubo, Yoshimitsu Shimomura, et al. · Journal of Infection and Chemotherapy · 5
PDF
Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation
2024 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · British Journal of Haematology · 4
PDF
Tumor lysis syndrome followed by tumor regression after COVID-19 in a patient with chronic lymphocytic leukemia
2023 · Masato Yasumi, Yudai Yamamoto, et al. · International Cancer Conference Journal · 3
PDF
Efficacy of letermovir in HLA-haploidentical hematopoietic transplantation with posttransplant cyclophosphamide
2023 · Daishi Nakagawa, Yoshimitsu Shimomura, et al. · International Journal of Hematology · 3
A Case of Tyrosine Kinase Inhibitor-Induced Bone Marrow Aplasia That Was Successfully Treated with Allogeneic Hematopoietic Stem Cell Transplantation
2021 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · Case Reports in Oncology · 3
Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy
2023 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · Blood · 2
PDF
PD ‐1 expression on tumour‐infiltrating cells is a prognostic factor for relapsed or refractory diffuse large B ‐cell lymphoma
2023 · Fumiya Wada, Kimimori Kamijo, et al. · Immunology · 2
PDF
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
2023 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · Annals of Hematology · 2
PDF
Mild Acute Graft-Versus-Host Disease Improves Outcomes After HLA-Haploidentical-Related Donor Transplantation Using Posttransplant Cyclophosphamide and Cord Blood Transplantation
2023 · Fumiya Wada, Junya Kanda, et al. · Cell Transplantation · 2
Prognostic impact of CD38 expression in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma transformation
2022 · Fumiya Wada, Yoshimitsu Shimomura, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
Trajectories of the SARS‐CoV ‐2 RNA load in patients with hematological malignancy
2023 · Satoshi Mitsuyuki, Masashi Nishikubo, et al. · European Journal Of Haematology · 1
Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2022 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · Blood · 1
Absence of Pretransplant Peripheral Blasts is Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia
2026 · Hiroyasu Ogawa, Katsuji Kaida, et al. · Transplantation and Cellular Therapy
Efficacy of Low-Dose Olanzapine for the Prevention of Conditioning Therapy-Induced Nausea and Vomiting in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
2026 · Kanae Yamashita, Kimimori Kamijo, et al. · Transplantation and Cellular Therapy
Non-germinal center diffuse large B-cell lymphoma arising from a common origin of duodenal-type follicular lymphoma
2025 · Tomoyo Kubo, Yuya Nagai, et al. · Journal of the Japan Society of the Reticuloendothelial System
PDF
Allogeneic Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma with Stable or Progressive Disease
2024 · Kimimori Kamijo, Yoshimitsu Shimomura, et al. · Blood
PDF
[Successful remission induction with reduced-dose all-trans retinoic acid for acute promyelocytic leukemia complicated by COVID-19].
2024 · Rintaro Fujimoto, Tsuyoshi Kamae, et al. · PubMed
[An elderly patient with lymphoplasmacytic lymphoma successfully treated with low-dose tirabrutinib].
2023 · Masato Yasumi, Kamma Shiraishi, et al. · PubMed
[Multiple microthromboses with autoimmune hemolytic anemia after BNT162b2 mRNA vaccination].
2023 · Yoshino Fujisaki, Masato Yasumi, et al. · PubMed
Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies
2022 · Masashi Nishikubo, Yoshimitsu Shimomura, et al. · Blood
Works count: 28
Citation count: 73
H-index: 5
I10-index: 1
Year
Topic
Type